<bill session="115" type="h" number="3348" updated="2017-09-11T02:55:18Z">
  <state datetime="2017-07-20">REFERRED</state>
  <status>
    <introduced datetime="2017-07-20"/>
  </status>
  <introduced datetime="2017-07-20"/>
  <titles>
    <title type="short" as="introduced">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="introduced">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
    <title type="official" as="introduced">To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome.</title>
    <title type="display">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
  </titles>
  <sponsor bioguide_id="P000608"/>
  <cosponsors>
    <cosponsor bioguide_id="B001296" joined="2017-07-20"/>
    <cosponsor bioguide_id="M001198" joined="2017-07-20"/>
    <cosponsor bioguide_id="R000598" joined="2017-07-20"/>
  </cosponsors>
  <actions>
    <action datetime="2017-07-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-07-20" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
